What AUC/MIC ratio optimizes vancomycin efficacy against MRSA?

AUC24/MIC ≥400 mg·h/L is required for clinical success in MRSA bacteremia. For isolates with MIC 2 mg/L, achieving target AUC (800 mg·h/L) often requires doses causing nephrotoxicity, favoring alternative agents.

What should be done if MRSA MIC is 2 mg/L and vancomycin is being used?

For MRSA with MIC ≥2 mg/L (heteroresistance or MIC creep), switch to alternative agents such as daptomycin, ceftaroline, or linezolid is strongly recommended, as adequate vancomycin AUC/MIC cannot be achieved safely.

Vancomycin AUC/MIC Target — MRSA Bacteremia Optimization

Calculate and interpret vancomycin AUC24/MIC ratio for MRSA bacteremia management, targeting 400–600 mg·h/L for therapeutic efficacy while minimizing nephrotoxicity risk in critically ill patients.

Use the full interactive calculator below, or

Vancomycin AUC/MIC Target — MRSA Bacteremia Optimization

Frequently Asked Questions

What AUC/MIC ratio optimizes vancomycin efficacy against MRSA?

What should be done if MRSA MIC is 2 mg/L and vancomycin is being used?